Clinical trials
Completed Phase 2 Stroke trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
210 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 6 |
| 2002 | 5 |
| 2003 | 10 |
| 2004 | 10 |
| 2005 | 8 |
| 2006 | 9 |
| 2007 | 6 |
| 2008 | 17 |
| 2009 | 12 |
| 2010 | 11 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 8 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 4 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 210 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| US Department of Veterans Affairs | 12 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 8 |
| University of Alberta | 5 |
| Duke University | 4 |
| Johns Hopkins University | 4 |
| Allergan | 3 |
| Astellas Pharma Inc | 3 |
| China Medical University Hospital | 3 |
| Neuroscience Trials Australia | 3 |
| Northwell Health | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 210 |
| Ischemic Stroke | 47 |
| Cerebrovascular Disorders | 13 |
| Paresis | 12 |
| Cerebral Hemorrhage | 10 |
| Brain Ischemia | 8 |
| Hemiplegia | 7 |
| Ischemia | 7 |
| Atrial Fibrillation | 6 |
| Central Nervous System Diseases | 6 |
Trials
Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.
110 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.